X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
respiratory system (196) 196
index medicus (166) 166
humans (131) 131
pulmonary hypertension (114) 114
male (97) 97
critical care medicine (87) 87
cardiac & cardiovascular systems (79) 79
female (68) 68
middle aged (58) 58
animals (54) 54
hypertension, pulmonary - physiopathology (52) 52
adult (50) 50
abridged index medicus (39) 39
rats (37) 37
aged (35) 35
arterial-hypertension (34) 34
heart failure (29) 29
physiology (29) 29
heart (27) 27
hemodynamics (27) 27
hypertension (27) 27
peripheral vascular disease (25) 25
exercise (24) 24
disease (23) 23
disease models, animal (23) 23
stroke volume (23) 23
hypertension, pulmonary - complications (22) 22
research (22) 22
diagnosis (21) 21
hypertension, pulmonary - pathology (21) 21
pulmonary arteries (21) 21
heart failure - physiopathology (19) 19
hypoxia (19) 19
right ventricle (19) 19
risk factors (19) 19
heart-failure (18) 18
hypertension, pulmonary - drug therapy (18) 18
pulmonary arterial hypertension (18) 18
rats, sprague-dawley (18) 18
treatment outcome (18) 18
care and treatment (17) 17
dysfunction (17) 17
ventricular dysfunction, right - physiopathology (17) 17
hypertension, pulmonary - diagnosis (16) 16
inflammation (16) 16
physiological aspects (16) 16
retrospective studies (16) 16
apoptosis (15) 15
cardiology (15) 15
echocardiography (15) 15
hematology (15) 15
lung (15) 15
magnetic resonance imaging (15) 15
pressure (15) 15
prognosis (15) 15
pulmonary artery - physiopathology (15) 15
cardiovascular (14) 14
cell biology (14) 14
lungs (14) 14
patients (14) 14
pulmonary arterial-hypertension (14) 14
analysis (13) 13
animal models (13) 13
familial primary pulmonary hypertension (13) 13
hypertension, pulmonary - metabolism (13) 13
mutation (13) 13
blood pressure (12) 12
cells, cultured (12) 12
expression (12) 12
fibrosis (12) 12
inhibition (12) 12
mice (12) 12
proteins (12) 12
survival (12) 12
usage (12) 12
ventricular function, right (12) 12
exercise - physiology (11) 11
exercise test (11) 11
hypertrophy (11) 11
hypertrophy, right ventricular - physiopathology (11) 11
research article (11) 11
cardiac catheterization (10) 10
cardiac-output (10) 10
cardiology and cardiovascular medicine (10) 10
chronic obstructive pulmonary disease (10) 10
failure (10) 10
health aspects (10) 10
heart diseases (10) 10
heart ventricles - pathology (10) 10
hypertension, pulmonary - etiology (10) 10
hypertension, pulmonary - mortality (10) 10
medicine & public health (10) 10
model (10) 10
prognostic value (10) 10
pulmonary artery (10) 10
pulmonary artery - pathology (10) 10
radiology, nuclear medicine & medical imaging (10) 10
ventricle (10) 10
ventricular function, right - physiology (10) 10
biochemistry & molecular biology (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Respiratory Journal, ISSN 0903-1936, 07/2017, Volume 50, Issue 1, pp. 1701191 - 1701191
Journal Article
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, ISSN 1073-449X, 06/2019, Volume 199, Issue 12, pp. 1458 - 1459
Journal Article
EUROPEAN RESPIRATORY JOURNAL, ISSN 0903-1936, 07/2016, Volume 48, Issue 1, pp. 285 - 285
Journal Article
European Respiratory Journal, ISSN 0903-1936, 04/2008, Volume 31, Issue 4, pp. 759 - 764
Journal Article
Circulation, ISSN 0009-7322, 03/2015, Volume 131, Issue 11, pp. 1006 - 1018
BACKGROUND—The vascular remodeling responsible for pulmonary arterial hypertension (PAH) involves predominantly the accumulation of α-smooth muscle... 
Human | Hypertension | Vimentin | Sirolimus | Twist1 protein | Vascular remodeling | Epithelial-mesenchymal transition | Neointima | Animal | Type ii | Models | Bone morphogenetic protein receptors | Cardiovascular diseases | Pulmonary | RAPAMYCIN | MIGRATION | FIBROSIS | models, animal | CARDIAC & CARDIOVASCULAR SYSTEMS | neointima | hypertension, pulmonary | vimentin | cardiovascular diseases | vascular remodeling | DISCOVERY | bone morphogenetic protein receptors, type II | IN-VITRO | sirolimus | TWIST1 protein, human | ARTERIAL-HYPERTENSION | PERIPHERAL VASCULAR DISEASE | epithelial-mesenchymal transition | SMOOTH-MUSCLE-CELLS | KNOCKOUT RATS | TRANSDIFFERENTIATION | Vascular Remodeling | Humans | Gene Expression Profiling | Hypertension, Pulmonary - chemically induced | Actins - genetics | RNA, Messenger - biosynthesis | Vimentin - genetics | Cell Transdifferentiation | Lung - metabolism | Disease Models, Animal | Lung - pathology | Actins - biosynthesis | Bone Morphogenetic Protein Receptors, Type II - genetics | Vimentin - biosynthesis | Cells, Cultured | Rats | Hypertension, Pulmonary - genetics | Hypoxia - complications | Monocrotaline - toxicity | Sirolimus - pharmacology | Animals | Biomarkers | Mutation | Endothelial Cells - pathology | Lung - blood supply | Hypertension, Pulmonary - pathology | Mesoderm - pathology | Bone Morphogenetic Protein Receptors, Type II - biosynthesis | Cell Movement | Index Medicus | Abridged Index Medicus | Life Sciences
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2011, Volume 58, Issue 24, pp. 2511 - 2519
Journal Article
Circulation, ISSN 0009-7322, 11/2009, Volume 120, Issue 20, pp. 1951 - 1960
Background-The most important determinant of longevity in pulmonary arterial hypertension is right ventricular (RV) function, but in contrast to experimental... 
Heart failure | Angiogenesis | Microcirculation | Pressure | Pulmonary heart disease | pulmonary heart disease | OVERLOAD | heart failure | CARDIAC & CARDIOVASCULAR SYSTEMS | angiogenesis | pressure | microcirculation | PROGNOSTIC VALUE | MYOSIN HEAVY-CHAIN | ANTIOXIDANT RESPONSE ELEMENT | TRANSCRIPTION FACTOR NRF2 | VENTRICULAR HYPERTROPHY | CARDIAC-HYPERTROPHY | DISEASE | GENE-EXPRESSION | PERIPHERAL VASCULAR DISEASE | HYPERTENSION | HEMATOLOGY | Blood Pressure | Vascular Endothelial Growth Factor A - biosynthesis | Heart Failure - physiopathology | Hypertension, Pulmonary - physiopathology | Male | RNA, Messenger - biosynthesis | Hypertrophy, Right Ventricular - physiopathology | Pulmonary Artery - metabolism | Heme Oxygenase (Decyclizing) - biosynthesis | Hypertrophy, Right Ventricular - pathology | Hypoxia-Inducible Factor 1, alpha Subunit - biosynthesis | Hypertrophy, Right Ventricular - metabolism | Disease Models, Animal | Gene Expression Regulation | Rats | Heart Failure - metabolism | Hypertension, Pulmonary - metabolism | Pulmonary Artery - physiopathology | Heart Failure - pathology | Rats, Sprague-Dawley | Animals | Fibrosis | Hypertension, Pulmonary - pathology | Pulmonary Artery - pathology | Ventricular Function, Right | Apoptosis | Usage | Animal models in research | Heart ventricle, Left | Physiological aspects | Diagnosis | Pulmonary hypertension | Index Medicus | Abridged Index Medicus
Journal Article
European Respiratory Journal, ISSN 0903-1936, 12/2016, Volume 48, Issue 6, pp. 1553 - 1555
Journal Article
Journal Article
European Respiratory Journal, ISSN 0903-1936, 05/2016, Volume 47, Issue 5, pp. 1315 - 1317
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 09/2010, Volume 182, Issue 5, pp. 652 - 660
Journal Article
Thorax, ISSN 0040-6376, 12/2017, Volume 72, Issue Suppl 3, p. A66
IntroductionChronic thromboembolic pulmonary hypertension (CTEPH) is an infrequent but important complication of acute pulmonary embolism (PE). Thrombophilias... 
Genomes | Thromboembolism | Health risk assessment | Blood groups | Pulmonary hypertension | Quality control
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 7, pp. 668 - 680
Abstract Background Endothelial cell (EC) dysfunction plays a central role in the pathogenesis of pulmonary arterial hypertension (PAH), promoting... 
Cardiovascular | Internal Medicine | β-blocker | nebivolol | inflammation | endothelial dysfunction | pulmonary hypertension | CELLS | CARDIAC & CARDIOVASCULAR SYSTEMS | beta-blocker | RATS | CROSS-TALK | THERAPY | SMOOTH-MUSCLE HYPERPLASIA | ARTERIAL-HYPERTENSION | ANIMAL-MODELS | BLOCKADE | PROGRESSION | Ethanolamines - pharmacology | Benzopyrans - therapeutic use | Cell Proliferation | Rats, Wistar | Metoprolol - pharmacology | Humans | Monocrotaline | Adrenergic beta-1 Receptor Antagonists - pharmacology | Hypertension, Pulmonary - physiopathology | Endothelium, Vascular - drug effects | Male | Adrenergic beta-1 Receptor Antagonists - therapeutic use | Hypertension, Pulmonary - drug therapy | Cell Culture Techniques | Vascular Remodeling - drug effects | Benzopyrans - pharmacology | Disease Models, Animal | Nebivolol | Endothelium, Vascular - physiopathology | Rats | Metoprolol - therapeutic use | Pulmonary Artery - physiopathology | Pulmonary Artery - drug effects | Animals | Myocytes, Smooth Muscle | Cell Communication - drug effects | Endothelium, Vascular - pathology | Ethanolamines - therapeutic use | Hypertension, Pulmonary - pathology | Pulmonary Artery - pathology | Endothelial Cells - drug effects | Heart | Sects | Pulmonary hypertension | Endothelium | Studies | Cell growth | Pulmonary arteries | Mortality | Smooth muscle | Veins & arteries | Index Medicus | Abridged Index Medicus | Life Sciences
Journal Article
Journal Article